Page last updated: 2024-10-30

meclofenamic acid and Nephrotic Syndrome

meclofenamic acid has been researched along with Nephrotic Syndrome in 6 studies

Meclofenamic Acid: A non-steroidal anti-inflammatory agent with antipyretic and antigranulation activities. It also inhibits prostaglandin biosynthesis.
meclofenamic acid : An aminobenzoic acid that is anthranilic acid in which one of the hydrogens attached to the nitrogen is replaced by a 2,6-dichloro-3-methylphenyl group. A non-steroidal anti-inflammatory drug, it is used as the sodium salt for the treatment of dysmenorrhoea (painful periods), osteoarthritis and rheumatoid arthritis.

Nephrotic Syndrome: A condition characterized by severe PROTEINURIA, greater than 3.5 g/day in an average adult. The substantial loss of protein in the urine results in complications such as HYPOPROTEINEMIA; generalized EDEMA; HYPERTENSION; and HYPERLIPIDEMIAS. Diseases associated with nephrotic syndrome generally cause chronic kidney dysfunction.

Research

Studies (6)

TimeframeStudies, this research(%)All Research%
pre-19905 (83.33)18.7374
1990's1 (16.67)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Torres, VE3
Velosa, JA3
Holley, KE2
Frohnert, PP1
Zincke, H1
Sterioff, S1
Anderson, CF1
Lagrue, G1
Branellec, A1
Blanc, C1
Xheneumont, S1
Beaudoux, F1
Sobel, A1
Weil, B1
Regester, RF1
Goldman, MH1
Donadio, JV1
Wagoner, RD1
Offord, KP1

Other Studies

6 other studies available for meclofenamic acid and Nephrotic Syndrome

ArticleYear
Meclofenamate treatment of recurrent idiopathic nephrotic syndrome with focal segmental glomerulosclerosis after renal transplantation.
    Mayo Clinic proceedings, 1984, Volume: 59, Issue:3

    Topics: Adult; Creatinine; Glomerulonephritis; Glomerulosclerosis, Focal Segmental; Humans; Kidney Transplan

1984
Meclofenamate and the nephrotic syndrome: the use of the right drug in the right patient by the right physician.
    Mayo Clinic proceedings, 1984, Volume: 59, Issue:3

    Topics: Humans; Judgment; Meclofenamic Acid; Nephrotic Syndrome; ortho-Aminobenzoates; Proteinuria

1984
A vascular permeability factor in lymphocyte culture supernants from patients with nephrotic syndrome. II. Pharmacological and physicochemical properties.
    Biomedicine / [publiee pour l'A.A.I.C.I.G.], 1975, Feb-28, Volume: 23, Issue:2

    Topics: Blood Proteins; Capillary Permeability; Cells, Cultured; Chemical Phenomena; Chemistry, Physical; Di

1975
Meclofenamate treatment of posttransplant nephrotic syndrome.
    Transplantation proceedings, 1991, Volume: 23, Issue:2

    Topics: Adult; Child; Humans; Kidney Transplantation; Male; Meclofenamic Acid; Nephrotic Syndrome; Postopera

1991
Benefits and risks of nonsteroidal antiinflammatory drugs in steroid-resistant nephrotic syndrome.
    American journal of kidney diseases : the official journal of the National Kidney Foundation, 1986, Volume: 8, Issue:5

    Topics: Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Drug Resistance; Glomerular Filtr

1986
Treatment of severe nephrotic syndrome with meclofenamate: an uncontrolled pilot study.
    Mayo Clinic proceedings, 1985, Volume: 60, Issue:9

    Topics: Adult; Female; Humans; Kidney Function Tests; Lipids; Male; Meclofenamic Acid; Middle Aged; Nephroti

1985